MX2009008122A - Composiciones farmaceuticas y metodos para utilizar temozolomida e inhibidores de quinasa multidirigidos. - Google Patents

Composiciones farmaceuticas y metodos para utilizar temozolomida e inhibidores de quinasa multidirigidos.

Info

Publication number
MX2009008122A
MX2009008122A MX2009008122A MX2009008122A MX2009008122A MX 2009008122 A MX2009008122 A MX 2009008122A MX 2009008122 A MX2009008122 A MX 2009008122A MX 2009008122 A MX2009008122 A MX 2009008122A MX 2009008122 A MX2009008122 A MX 2009008122A
Authority
MX
Mexico
Prior art keywords
methods
temozolomide
pharmaceutical compositions
kinase inhibitors
targeted kinase
Prior art date
Application number
MX2009008122A
Other languages
English (en)
Inventor
Walter Robert Bishop
Yaolin Wang
Ming Liu
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39596806&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2009008122(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of MX2009008122A publication Critical patent/MX2009008122A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención proporciona formulaciones, paquetes, y métodos útiles para el tratamiento de un trastorno proliferativo de células; en particular, las formulaciones, paquetes y métodos incluyen temozolomida (TMZ) en combinación con un inhibidor de quinasa multidirigido.
MX2009008122A 2007-01-30 2008-01-28 Composiciones farmaceuticas y metodos para utilizar temozolomida e inhibidores de quinasa multidirigidos. MX2009008122A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88724507P 2007-01-30 2007-01-30
PCT/US2008/001061 WO2008094484A2 (en) 2007-01-30 2008-01-28 Pharmaceutical compositions and methods of using temozolomide and multi-targeted kinase inhibitors

Publications (1)

Publication Number Publication Date
MX2009008122A true MX2009008122A (es) 2009-08-12

Family

ID=39596806

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009008122A MX2009008122A (es) 2007-01-30 2008-01-28 Composiciones farmaceuticas y metodos para utilizar temozolomida e inhibidores de quinasa multidirigidos.

Country Status (10)

Country Link
US (1) US20100087499A1 (es)
EP (1) EP2125020A2 (es)
JP (1) JP2010516771A (es)
AR (1) AR065077A1 (es)
CA (1) CA2676168A1 (es)
CL (1) CL2008000229A1 (es)
MX (1) MX2009008122A (es)
PE (1) PE20090486A1 (es)
TW (1) TW200838506A (es)
WO (1) WO2008094484A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI386203B (zh) 2011-01-07 2013-02-21 Univ China Medical 治療腦癌或用以降低腦癌細胞對替莫唑胺之抗藥性之醫藥組合物及其應用
CN104140414B (zh) * 2013-05-07 2018-12-11 江苏豪森药业集团有限公司 阿昔替尼晶型的制备方法
JP6542791B2 (ja) 2014-03-10 2019-07-10 カドモン コーポレイション，リミティド ライアビリティ カンパニー 脳及び中枢神経系腫瘍の治療
WO2017037298A1 (en) * 2015-09-04 2017-03-09 Aslan Pharmaceuticals Pte Limited A combination therapy comprising varlitinib and an anticancer agent
CN117919234A (zh) * 2022-10-25 2024-04-26 上海润石医药科技有限公司 一种萘酰胺化合物治疗耐药性肿瘤的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939098A (en) * 1996-09-19 1999-08-17 Schering Corporation Cancer treatment with temozolomide
US20080193448A1 (en) * 2005-05-12 2008-08-14 Pfizer Inc. Combinations and Methods of Using an Indolinone Compound
WO2007056117A1 (en) * 2005-11-04 2007-05-18 Wyeth Antineoplastic combinations of temsirolimus and sunitinib malate

Also Published As

Publication number Publication date
CA2676168A1 (en) 2008-08-07
JP2010516771A (ja) 2010-05-20
EP2125020A2 (en) 2009-12-02
US20100087499A1 (en) 2010-04-08
WO2008094484A3 (en) 2008-10-02
CL2008000229A1 (es) 2008-08-01
PE20090486A1 (es) 2009-04-27
TW200838506A (en) 2008-10-01
WO2008094484A2 (en) 2008-08-07
AR065077A1 (es) 2009-05-13

Similar Documents

Publication Publication Date Title
EA201000219A1 (ru) Способ и композиция для лечения в-клеточных пролиферативных нарушений
MX2010002336A (es) Derivados de 2-bifenil-amino-4-amino-pirimidina como inhibidores de cinasa.
TW200801008A (en) Protein kinase inhibitors
TW200738263A (en) ANG2 and VEGF inhibitor combinations
MX339584B (es) Inhibidores de pi3 cinasa y usos de los mismos.
MX2010006154A (es) Tratamiento del cancer con combinaciones de inhibidores de la topoisomerasa e inhibidores de la poli-adp-ribosa-polimerasa.
MX354402B (es) Inhibidores de molecula pequeña del dominio de homologia de pleckstrin y metodos para usar los mismos.
IN2012DN00471A (es)
EP2603216A4 (en) HETEROARYLE AND USES THEREOF
UY31929A (es) Compuestos y composiciones como inhibidores de cinasa
WO2010138820A3 (en) N,n-diarylurea compounds and n,n'-diarylthiourea compounds as inhibitors of translation initiation
MY153727A (en) Pyridazinone derivatives
AR048819A1 (es) Metodos sinergicos y composiciones para el tratamiento del cancer
MY146989A (en) Kinase inhibitors
WO2008063558A3 (en) Combination of an inhibitor of dna polymerase-alpha and an inhibitor of a checkpoint kinase for proliferative disorders
IN2012DN03012A (es)
WO2010118063A3 (en) Pyruvate kinase m2 modulators, therapeutic compositions and related methods of use
MX2009009117A (es) Derivados de pirimidin-2,4-diamina y su uso como inhibidores de la cinasa jak2.
MX2011009568A (es) Inhibidores de la rho cinasa.
CL2008001633A1 (es) Compuestos derivados de pirrolidin-3-carboxamida; composición farmacéutica; y uso comominhibidores de erk para el tratamiento del cancer.
MX2009006627A (es) Quinazolinas para la inhibicion de pdk1.
UA99284C2 (ru) ИНГИБИТОРЫ р70 S6-КИНАЗЫ
CL2008002097A1 (es) Compuestos derivados de heterociclos condensados sustituidos, inhibidores de cinasa de fosfatidil-inositol-3; composicion farmaceutica; y uso en el tratamiento del cancer.
EA200801430A1 (ru) Производные триазола
WO2007067781A3 (en) 9-membered heterobicyclic compounds as inhibitors of protein kinases